M. R. Dintzner et al. / Tetrahedron Letters 50 (2009) 6639–6641
6641
4. (a) Kawabata, T.; Kato, M.; Mizugaki, T.; Ebitani, K.; Kaneda, K. Chem. Eur. J. 2005,
11, 288; (b) Jin, Y. Z.; Yasuda, N.; Furuno, H.; Inanaga, J. Tetrahedron Lett. 2003,
44, 8765; (c) Sasidharan, M.; Tatsumi, T. Chem. Lett. 2003, 32, 624.
147.12, 133.96, 131.99, 129.06, 122.12, 120.89, 117.88, 73.75, 44.88, 0.05; GC–
MS (70 eV), tR = 18.158 min, m/z 265 (<1%); 250 [MÀ15]+ (2%); 224 [MÀ41]+
(50%); 73 [MÀ192]+ (100%). 1-Nitro-4-[1-[(trimethylsilyl)oxy]-3-buten-1-yl]benzene
(2c): IR (CDCl3) 3079, 2958, 2903, 1641, 1607, 1522, 1492, 1432, 1416, 1350,
5. (a) Dintzner, M. R.; Little, A. J.; Pacilli, M.; Pileggi, D.; Osner, Z. R.; Lyons, T. W.
Tetrahedron Lett. 2007, 48, 1577; (b) Dintzner, M. R.; Wucka, P.; Lyons, T. W. J.
Chem. Educ. 2006, 83, 270; (c) Dintzner, M. R.; Lyons, T. W.; Akroush, M. H.;
Wucka, P.; Rzepka, A. T. Synlett 2005, 5, 785; (d) Dintzner, M. R.; McClelland, K.
M.; Morse, K. M.; Akroush, M. H. Synlett 2004, 11, 2028; (e) Dintzner, M. R.;
Morse, K. M.; McClelland, K. M.; Coligado, D. M. Tetrahedron Lett. 2004, 45, 79.
6. Dintzner, M. R.; Pacilli, M.; Pileggi, D. J.; Zuziak, M. M. From Abstracts of Papers,
235th National Meeting of the American Chemical Society, New Orleans, LA;
American Chemical Society: Washington, DC, 2008; CHED 551.
1316, 1292, 1253 cmÀ1 1H NMR (300 MHz, CDCl3) d 8.19 (d, J = 8.29 Hz, 2H),
;
7.49 (d, J = 8.29 Hz, 2H), 5.74 (m, 1H), 5.03 (m, 2H), 4.80 (dd, J = 5.65, 6.78 Hz,
1H)2.45 (m, 2H), 0.08 (s, 9H); 13C NMR (75 MHz, CDCl3) d 152.37, 147.06,
133.93, 126.63, 123.43, 117.85, 73.85, 44.79, 0.02; GC–MS (70 eV),
tR = 20.424 min, m/z 265 M+ (<1%); 224 [MÀ41]+ (70%); 73 [MÀ192]+ (100%).
1-Fluoro-3-[1-[(trimethylsilyl)oxy]-3-buten-1-yl]benzene (2d): IR (CDCl3) 3078,
2957, 2903, 1704, 1642, 1616, 1593, 1489, 1450, 1359, 1252 cmÀ1 1H NMR
;
(300 MHz, CDCl3) d 7.30 (m, 1H), 7.10 (m, 2H), 6.95 (m, 1H), 5.80 (m, 1H), 5.06
(m, 2H), 4.72 (dd, J = 5.46, 7.16 Hz, 1H), 2.48 (m, 2H), 0.11 (s, 9H); 13C NMR
(75 MHz, CDCl3) d 147.73, 146.57, 134.77, 130.20, 121.4, 118.94, 113.97, 112.61,
72.56, 43.82, 0.06; GC–MS (70 eV), tR = 8.711 min, m/z 238 M+ (<1%); 223
[MÀ15]+ (5%); 197 [MÀ41]+ (100%); 73 [MÀ165]+ (95%). 1-Chloro-4-[1-
[(trimethylsilyl)oxy]-3-buten-1-yl]benzene (2e): IR (CDCl3) 3078, 2958, 2903,
7. Yahiaoui, A.; Belbachir, M.; Hachemaoui, A. Int. J. Mol. Sci. 2003, 4, 458.
8. Bottoni, A.; Costa, A. L.; Di Tommaso, D.; Rossi, I.; Tagliavini, E. J. Am. Chem. Soc.
1997, 119, 12131.
9. Analytical data for compounds 2a–g: Proton nuclear magnetic resonance (1H)
spectra and carbon-13
(
13C) spectra were recorded at 400 and 100 MHz,
respectively. The proton signal of residual, non-deuterated solvent (d 7.26 ppm
for CHCl3) was used as an internal reference for 1H spectra. For 13C spectra,
chemical shifts are reported relative to the d 77.23 ppm resonance of CDCl3.
Coupling constants are reported in Hz. Infrared spectra were recorded as thin
films on a Nicolet Avatar 360. Gas chromatographic analysis was performed on a
Hewlett–Packard 5890 Series II gas chromatograph with a 5971 Series mass
selective detector. 1-Nitro-2-[1-[(trimethylsilyl)oxy]-3-buten-1-yl]benzene (2a):
IR (CDCl3) 3077, 2958, 1701, 1641, 1610, 1577, 1527, 1445, 1346, 1298.
1641, 1598, 1491, 1432, 1409, 1360, 1295, 1262, 1252 cmÀ1 1H NMR (300 MHz,
;
CDCl3) d 7.30 (m, 4H), 5.77 (m, 1H), 5.05 (m, 2H), 4.68 (dd, J = 5.46, 7.35 Hz, 1H),
2.43 (m, 2H), 0.07 (s, 9H); 13C NMR (75 MHz, CDCl3) d 143.41, 134.77, 132.62,
128.06, 127.28, 117.20, 74.17, 45.04, 0.10; GC–MS (70 eV), tR = 11.263 min, m/z
254/256 M+/M+2 (<1%); 213/215 [MÀ41]+ (98%); 73 [MÀ181]+ (100%). 1,3-
Dichloro-2-[1-[(trimethylsilyl)oxy]-3-buten-1-yl]benzene (2f): IR (CDCl3) 3078,
2958, 1642, 1581, 1562, 1437, 1251 cmÀ1 1H NMR (300 MHz, CDCl3) d 7.29
;
(m, 2H), 7.11 (m, 1H), 5.81 (m, 1H), 5.50 (m, 1H), 5.05 (dd, J = 6.40, 8.10 Hz, 1H),
2.86 (m, 1H), 2.68 (m, 1H), 0.04 (s, 9H); 13C NMR (75 MHz, CDCl3) d 137.92,
134.73, 129.38, 128.93, 128.60, 117.16, 71.45, 40.00, 0.12; GC–MS (70 eV),
tR = 13.209 min, m/z 288/290/292 M+/M+2/M+4 (<1%); 247/249/251 [MÀ41]+
(93%); 73 [MÀ215]+ (100%). 3-[1-[(Trimethylsilyl)oxy]-3-buten-1-yl]benzonitrile
(2g): IR (CDCl3) 3078, 2958, 2902, 2230, 1641, 1602, 1584, 1482, 1434, 1359,
1252 cmÀ1 1H NMR (300 MHz, CDCl3) d 7.89 (m, 2H), 7.63 (m, 1H), 7.40 (m, 1H),
;
5.86 (m, 1H), 5.38 (dd, J = 4.05, 7.63 Hz), 5.07 (m, 2H), 2.52, (m, 1H), 2.41 (m,
1H), 0.05 (s, 9H); 13C NMR (75 MHz, CDCl3) d 147.17, 140.64, 139.31, 134.46,
133.12, 128.63, 127.72, 123.98, 117.59, 69.63, 44.24, 0.27; GC–MS (70 eV),
tR = 11.843 min, m/z 265 M+ (<1%); 224 [MÀ41]+ (60%); 73 [MÀ192]+ (100%). 1-
Nitro-3-[1-[(trimethylsilyl)oxy]-3-buten-1-yl]benzene (2b): IR (CDCl3) 3077, 2958,
1285, 1252 cmÀ1 1H NMR (300 MHz, CDCl3) d 7.62 (m, 1H), 7.53 (m, 2H), 7.42
;
2902, 1641, 1432, 1479, 1437, 1351, 1310, 1252 cmÀ1
;
1H NMR (300 MHz,
(m, 1H), 5.73 (m, 1H), 5.01 (m, 2H), 4.72 (dd, J = 5.65, 6.78 Hz, 1H), 2.41 (m, 2H),
0.06 (s, 9H); 13C NMR (75 MHz, CDCl3) d 146.41, 134.01, 130.76, 130.33, 129.55,
119.00, 117.79, 112.16, 73.73, 44.89, 0.04; GC–MS (70 eV), tR = 14.267, m/z 245
M+ (<1%); 230 [MÀ15]+ (10%); 204 [MÀ41]+ (98%); 73 [MÀ172]+ (100%).
CDCl3) d 8.19 (s, 1H), 8.10 (ddd, J = 1.13, 2.26, 8.1 Hz, 1H), 7.66 (d, J = 7.72 Hz,
1H), 7.49 (t, J = 7.91 Hz, 1H), 5.75 (m, 1H), 5.02 (m, 2H), 4.81 (dd, J = 5.56,
6.88 Hz, 1H), 2.45 (m, 2H), 0.07 (s, 9H); 13C NMR (75 MHz, CDCl3) d 148.21,